Work

Long-term survival with 90yttrium ibritumomab tiuxetan and rituximab as treatment for relapsed or refractory diffuse large B-cell lymphoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.8558

Authors: Jon E. Arnason, Katarina Luptakova, Jacalyn Rosenblatt, Jeffrey Zwicker, James D. Levine, Vassiliki Boussiotis, Michelle Kim, David Avigan, Robin Joyce

Institutions: Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598704008

Cites:

Cited by: 1

Related to: 10